Yield10 Bioscience, Inc. financial data

Symbol
YTEN on OTC
Location
19 Presidential Way, Suite 201, Woburn, MA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
METABOLIX, INC. (to 1/6/2017), METABOLIX INC (to 7/14/2006)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 35.6 % -84.1%
Debt-to-equity -247 % -292%
Return On Equity 436 %
Return On Assets -296 % -58.7%
Operating Margin -1.68K % +69.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 657K shares -89.3%
Common Stock, Shares, Outstanding 642K shares -89.5%
Entity Public Float 9.84M USD +11%
Common Stock, Value, Issued 6K USD -90.2%
Weighted Average Number of Shares Outstanding, Basic 642K shares +169%
Weighted Average Number of Shares Outstanding, Diluted 642K shares +169%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 750K USD +191%
Costs and Expenses 13.3M USD -7.46%
Operating Income (Loss) -12.6M USD +11.1%
Nonoperating Income (Expense) -109K USD -348%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.5M USD -7.79%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -12.7M USD +10.9%
Earnings Per Share, Basic 22 USD/shares +67.3%
Earnings Per Share, Diluted 22 USD/shares +67.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 733K USD -68.6%
Cash, Cash Equivalents, and Short-term Investments 1.07M USD -75.4%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 1.2M USD -60.2%
Property, Plant and Equipment, Net 432K USD -34.8%
Operating Lease, Right-of-Use Asset 1.3M USD -29.9%
Other Assets, Noncurrent 23K USD -65.7%
Assets 2.97M USD -49.4%
Accounts Payable, Current 2.37M USD +407%
Employee-related Liabilities, Current 647K USD +134%
Accrued Liabilities, Current 1.83M USD +32.9%
Liabilities, Current 7.67M USD +210%
Operating Lease, Liability, Noncurrent 1.09M USD -41%
Other Liabilities, Noncurrent 5K USD -58.3%
Liabilities 9.21M USD +74.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -262K USD -7.38%
Retained Earnings (Accumulated Deficit) -420M USD -3.12%
Stockholders' Equity Attributable to Parent -6.24M USD -1163%
Liabilities and Equity 2.97M USD -49.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -903K USD +66.1%
Net Cash Provided by (Used in) Financing Activities 1.21M USD +759%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 150M shares +150%
Common Stock, Shares, Issued 642K shares -89.5%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -547K USD +82.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 745K USD -71.3%
Deferred Tax Assets, Valuation Allowance 14.5M USD +35.4%
Deferred Tax Assets, Gross 15M USD +32.1%
Operating Lease, Liability 2.19M USD -17.2%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.7M USD +10.9%
Lessee, Operating Lease, Liability, to be Paid 2.88M USD -20.3%
Property, Plant and Equipment, Gross 2.05M USD +1.64%
Operating Lease, Liability, Current 676K USD +7.64%
Lessee, Operating Lease, Liability, to be Paid, Year Two 833K USD +8.04%
Lessee, Operating Lease, Liability, to be Paid, Year One 810K USD +8.14%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 264K USD -35.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 786K USD -0.88%
Deferred Tax Assets, Operating Loss Carryforwards 9.78M USD +40.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 25K USD -96.7%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 66K USD -4.35%
Deferred Tax Assets, Net of Valuation Allowance 480K USD -23.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%